Table 4 Demographic and management of transplant recipients with airway complications.
Patient number | Age/Gender | Disease necessitating transplantation | Detection date (days after transplantation but before occurrence of airway complication) | Airway complication ((Location) MDS classification) | Intervention (total number of times) |
|---|---|---|---|---|---|
1 | 56/Male | IPF | 30 | Stenosis ((L) M2cD3bS0) | Stenting (1) |
2 | 29/Female | Humidifier disinfectant–related lung disease | 84 | Stenosis ((R) M0D3dS0) | Balloon dilatation (3), stenting (1) |
3 | 53/Male | Drowning | 140 | Stenosis ((R) M2aD3aS0) | Balloon dilatation (1) |
4 | 61/Male | IPF | 83 | Stenosis ((R) M2bD3bS0) | Balloon dilatation (1) |
5 | 56/Male | CTD-related ILD | 56 | Stenosis ((R)M1aD3aS0) | Balloon dilatation (1) |
6 | 53/Male | IPF | 115 | Stenosis ((R) M2aD3aS0) | Balloon dilatation (3), stenting (1) |
7 | 66/Male | IPF | 139 | Stenosis ((R) M2bD3bS0) | None |
8 | 66/Male | IPF | 55 | Necrosis ((L) M3aD0S0) | None |
9 | 50/Male | IPF | 46 | Stenosis ((R) M2aD3aS0), Ischemia ((L) M2aD0S0) | Balloon dilatation (2), stenting (1) |
10 | 56/Male | IPF | 403 | Stenosis ((R)M2aD3aS0) | None |
11 | 62/Male | IPF | 41 | Stenosis ((L) M3aD2aS0) | Balloon dilatation (1) |
12 | 60/Female | IPF | 144 | Stenosis ((R) M2bD2bS0) | Balloon dilatation (2) |
13 | 53/Male | NSIP | 104 | Bronchomalacia ((R) M2aD1S0) | Balloon dilatation (1), stenting (1) |
14 | 64/Male | IPF | 79 | Ischemia ((L) M3bD0S0) | None |
15 | 62/Male | CPFE | 155 | Stenosis ((L) M1aD2aS0) | None |
16 | 55/Male | IIP | 77 | Stenosis ((R) M2bD3bS0, (L) M2bD3bS0) | Balloon dilatation (2) |
17 | 56/Male | IPF | 196 | Stenosis ((R) M1aD3aS0) | Balloon dilatation (1) |
18 | 56/Male | IPF | 140 | Stenosis ((R) M1bD3bS0, (L) M1bD2bS0) | Balloon dilatation (2), stenting (1) |
19 | 67/Male | IPF | 143 | Stenosis ((L) M1aD3aS0) | Balloon dilatation (4) |
20 | 48/Female | IPAH | 116 | Stenosis ((R) M2aD2aS0) | Balloon dilatation (1) |
21 | 59/Male | AIP | 16 | Ischemia ((R) M3aD0S0, (L) M3cD0S0) | None |
22 | 54/Male | Bronchiectasis, COPD | 135 | Stenosis ((R) M0D3dS0, (L) M0D3dS0) | Balloon dilatation (6) |
23 | 32/Male | NSIP | 99 | Stenosis ((R) M0cD2cS0) | Balloon dilatation (5), stenting (1) |
24 | 38/Male | CTEPH | 15 | Necrosis ((L) M3cD0S0) | None |
25 | 65/Female | IPF | 123 | Stenosis ((R) M1bD3bS0) | Balloon dilatation (2), stenting (1) |
26 | 63/Female | IPF | 95 | Stenosis ((R) M2aD2aS0) | Balloon dilatation (2), stenting (1) |
27 | 46/Male | OP | 21 | Ischemia ((R)M3aD0S0, (L) M3bD0S0) | None |
28 | 60/Female | Bronchiectasis | 22 | Ischemia ((R) M3aD0S0, (L) M3aD0S0) | None |
29 | 65/Female | CTD-related ILD | 42 | Stenosis ((R) M2aD3aS0, (L) M2aD0S0) | Balloon dilatation (3) |
30 | 37/Female | NSIP | 64 | Stenosis ((L) M2cD2CS0), bronchomalacia ((R) M0D1S0) | Balloon dilatation (1) |
